Nancy Ryan Gray Insider Trading $LGND LIGAND PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Nancy Ryan Gray.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Nancy Ryan Gray. Nancy Ryan Gray is Director in LIGAND PHARMACEUTICALS INC ($LGND).
Nancy Ryan Gray in LIGAND PHARMACEUTICALS INC
Trading Symbol: LGNDIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Nancy Ryan Gray: Director
Holdings: 3,702 shares
Current Value: $399,224
Latest Transaction: Jun 07 2021
$LGND Market Capitalization: $2.24B
$LGND Previous Close: $107.84
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Nancy Ryan Gray in LIGAND PHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Gray Nancy Ryan | Director | Option Exercise | A | 115.39 | 3,269 | 377,210 | 3,269 | |
Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Gray Nancy Ryan | Director | Grant | A | 0.00 | 630 | 0 | 3,702 | 3.1 K to 3.7 K (+20.51 %) |
Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Gray Nancy Ryan | Director | Option Exercise | A | 115.39 | 3,269 | 377,210 | 3,269 | |
Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Gray Nancy Ryan | Director | Grant | A | 0.00 | 630 | 0 | 3,702 | 3.1 K to 3.7 K (+20.51 %) |
Jun 12 2020 | LGND | LIGAND PHARMACEUTI ... | Gray Nancy Ryan | Director | Option Exercise | A | 117.58 | 2,468 | 290,187 | 2,468 | |
Jun 12 2020 | LGND | LIGAND PHARMACEUTI ... | Gray Nancy Ryan | Director | Grant | A | 0.00 | 831 | 0 | 3,072 | 2.2 K to 3.1 K (+37.08 %) |
Jun 07 2019 | LGND | LIGAND PHARMACEUTI ... | Gray Nancy Ryan | Director | Option Exercise | A | 113.59 | 4,071 | 462,425 | 4,071 | |
Jun 07 2019 | LGND | LIGAND PHARMACEUTI ... | Gray Nancy Ryan | Director | Grant | A | 0.00 | 835 | 0 | 2,241 | 1.4 K to 2.2 K (+59.39 %) |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | Gray Nancy Ryan | Director | Option Exercise | A | 76.77 | 2,474 | 189,929 | 2,474 | |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | Gray Nancy Ryan | Director | Option Exercise | A | 76.77 | 2,474 | 189,929 | 2,474 | |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | Gray Nancy Ryan | Director | Grant | A | 0.00 | 493 | 0 | 1,406 | 913 to 1.4 K (+54.00 %) |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | Gray Nancy Ryan | Director | Grant | A | 0.00 | 493 | 0 | 1,406 | 913 to 1.4 K (+54.00 %) |
Aug 22 2017 | LGND | LIGAND PHARMACEUTI ... | Gray Nancy Ryan | Director | Option Exercise | A | 126.26 | 3,452 | 435,850 | 3,452 | |
Aug 22 2017 | LGND | LIGAND PHARMACEUTI ... | Gray Nancy Ryan | Director | Grant | A | 0.00 | 913 | 0 | 913 | 0 to 913 |
Page: 1